Bessemer Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-733
| Closed | -$109K | – | 2461 |
|
2024
Q3 | $109K | Buy |
733
+102
| +16% | +$15.2K | ﹤0.01% | 1269 |
|
2024
Q2 | $86K | Sell |
631
-245
| -28% | -$33.4K | ﹤0.01% | 1200 |
|
2024
Q1 | $132K | Buy |
876
+332
| +61% | +$50K | ﹤0.01% | 1117 |
|
2023
Q4 | $69K | Hold |
544
| – | – | ﹤0.01% | 1279 |
|
2023
Q3 | $51K | Hold |
544
| – | – | ﹤0.01% | 1339 |
|
2023
Q2 | $49K | Hold |
544
| – | – | ﹤0.01% | 1380 |
|
2023
Q1 | $58K | Buy |
+544
| New | +$58K | ﹤0.01% | 1189 |
|
2022
Q2 | – | Sell |
-78
| Closed | -$9K | – | 1870 |
|
2022
Q1 | $9K | Hold |
78
| – | – | ﹤0.01% | 1397 |
|
2021
Q4 | $10K | Hold |
78
| – | – | ﹤0.01% | 1414 |
|
2021
Q3 | $12K | Hold |
78
| – | – | ﹤0.01% | 1324 |
|
2021
Q2 | $10K | Hold |
78
| – | – | ﹤0.01% | 1339 |
|
2021
Q1 | $10K | Buy |
+78
| New | +$10K | ﹤0.01% | 1298 |
|